The Latest Breaking News from Pfizer

Investors cheered a breakthrough drug pricing agreement between President Donald Trump and Pfizer Inc. (NYSE:PFE), sparking a sector-wide surge in health care stocks that delivered the biggest rally in five years.

Trump has been urging prescription drug manufacturers to lower U.S. prices.

Pfizer Inc's (NYSE:PFE) deal with Washington isn't just a handshake in the Oval Office — it's a seismic jolt to America's drug-pricing game. By agreeing to sell medicines on the government's new TrumpRx platform at steep discounts and extend "most favored nation" (MFN) pricing to Medicaid, Pfizer bought itself a…

Mark Cuban, the billionaire entrepreneur and investor, has given a cautious “B” grade to President Donald Trump’s new online drug store venture, TrumpRx.gov. 

Donald Trump sparked laughter in the Oval Office after cracking a COVID-19 joke when Secretary Kennedy sneezed during a meeting. The remark has drawn both chuckles and criticism online.

Trump announced a website for consumers to buy medicines at heavily discounted prices. He also forged a deal with Pfizer, where the drugmaker will slash prices for several of its products.

December S&P 500 E-Mini futures (ESZ25) are trending down -0.56% this morning as sentiment took a hit after the U.S. government shut down for the first time in seven years.

Under the deal, New York-based Pfizer will charge most-favoured-nation pricing to Medicaid and guarantee that pricing on newly launched drugs, Trump said. That involves matching the lowest price offered in other developed nations.

TrumpRx will slash US drug prices by up to 85% under a new deal with Pfizer, bringing costs in line with other nations and boosting US investment.